{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:39:55Z","timestamp":1782362395025,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Sheila Sherlock Entry-Lever Research Fellowship"},{"name":"European Association for the Study of Liver (EASL)"},{"name":"Higher Education Funding Council for England"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.cca.2012.03.020","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T08:15:29Z","timestamp":1333527329000},"page":"1211-1216","source":"Crossref","is-referenced-by-count":50,"title":["Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis"],"prefix":"10.1016","volume":"413","author":[{"given":"Maria G.","family":"Mytilinaiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Scheper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini I.","family":"Rigopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas L.","family":"Koutsoumpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Abeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew K.","family":"Burroughs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2012.03.020_bb0005","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2012.03.020_bb0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1089-3261(03)00104-1","article-title":"Antimitochondrial and other autoantibodies","volume":"7","author":"Bogdanos","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cca.2012.03.020_bb0015","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cca.2010.12.019","article-title":"Disease-specific autoantibodies in primary biliary cirrhosis","volume":"412","author":"Bogdanos","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2012.03.020_bb0020","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cca.2012.03.020_bb0025","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/gut.2003.036558","article-title":"Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis","volume":"54","author":"Rigopoulou","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cca.2012.03.020_bb0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","article-title":"Antinuclear antibodies specific for primary biliary cirrhosis","volume":"2","author":"Worman","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2012.03.020_bb0035","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1365-2036.2006.03172.x","article-title":"Antinuclear antibodies giving the \u2018multiple nuclear dots\u2019 or the \u2018rim-like\/membranous\u2019 patterns: diagnostic accuracy for primary biliary cirrhosis","volume":"24","author":"Granito","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cca.2012.03.020_bb0040","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1572-0241.2003.07257.x","article-title":"Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis","volume":"98","author":"Muratori","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2012.03.020_bb0045","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1365-2249.2002.01719.x","article-title":"Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders","volume":"127","author":"Muratori","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cca.2012.03.020_bb0050","first-page":"553","article-title":"Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis","volume":"55","author":"Bernstein","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cca.2012.03.020_bb0055","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.4049\/jimmunol.145.12.4338","article-title":"Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis","volume":"145","author":"Szostecki","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2012.03.020_bb0060","first-page":"108","article-title":"Autoimmune sera recognize a 100kD nuclear protein antigen (sp-100)","volume":"68","author":"Szostecki","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cca.2012.03.020_bb0065","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-3083.1995.tb03652.x","article-title":"Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis","volume":"42","author":"Sternsdorf","year":"1995","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cca.2012.03.020_bb0070","first-page":"1123","article-title":"Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis","volume":"26","author":"Zuchner","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2012.03.020_bb0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2007-1007184","article-title":"Autoantibodies against \u201cnuclear dots\u201d in primary biliary cirrhosis","volume":"17","author":"Szostecki","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cca.2012.03.020_bb0080","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","article-title":"PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis","volume":"35","author":"Liu","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cca.2012.03.020_bb0085","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1080\/00365520310004876","article-title":"Clinical significance of anti-multiple nuclear dots\/Sp100 autoantibodies","volume":"38","author":"Wichmann","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cca.2012.03.020_bb0090","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1572-0241.2004.04119.x","article-title":"Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain","volume":"99","author":"Bogdanos","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2012.03.020_bb0095","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1111\/j.1572-0241.2004.40416.x","article-title":"Serum immunological profile in patients with chronic autoimmune cholestasis","volume":"99","author":"Romero-Gomez","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2012.03.020_bb0100","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1590-8658(03)00466-3","article-title":"Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection","volume":"35","author":"Bogdanos","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cca.2012.03.020_bb0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/excr.1996.0368","article-title":"The PML and PML\/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic","volume":"229","author":"Andre","year":"1996","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cca.2012.03.020_bb0110","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1373\/clinchem.2008.118299","article-title":"New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies","volume":"55","author":"Dahnrich","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2012.03.020_bb0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-8278(03)00501-4","article-title":"Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis","volume":"40","author":"Bogdanos","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.cca.2012.03.020_bb0120","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.20788","article-title":"Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic","volume":"42","author":"Bogdanos","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2012.03.020_bb0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0168-8278(01)00252-5","article-title":"Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis","volume":"36","author":"Bogdanos","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cca.2012.03.020_bb0130","article-title":"Overcoming a \u201cprobable\u201d diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature","author":"Bizzaro","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cca.2012.03.020_bb0135","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1600-0625.2007.00592.x","article-title":"Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies","volume":"16","author":"Sitaru","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.cca.2012.03.020_bb0140","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/pmic.200300381","article-title":"Matrix-assisted laser desorption\/ionization-quadrupole ion trap-time of flight mass spectrometry sequencing resolves structures of unidentified peptides obtained by in-gel tryptic digestion of haptoglobin derivatives from human plasma proteomes","volume":"3","author":"Koy","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/j.cca.2012.03.020_bb0145","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cca.2007.01.023","article-title":"Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis","volume":"380","author":"Rigopoulou","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2012.03.020_bb0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2249.2010.04288.x","article-title":"Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis","volume":"163","author":"Stinton","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cca.2012.03.020_bb0155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.2003.07270.x","article-title":"Positive markers in AMA-negative PBC","volume":"98","author":"Vergani","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2012.03.020_bb0160","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.4049\/jimmunol.149.12.4067","article-title":"IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis","volume":"149","author":"Guldner","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2012.03.020_bb0165","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1083\/jcb.139.7.1621","article-title":"Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1\/SUMO-1","volume":"139","author":"Sternsdorf","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cca.2012.03.020_bb0170","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1016\/S0168-8278(09)60680-2","article-title":"Diagnostic and clinical application of a new line immunoassay that simultaneously detects the multiple nuclear dot specific antigens in primary piliary cirrhosis","volume":"50","author":"Mytilinaiou","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.cca.2012.03.020_bb0175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ajg.2009.596","article-title":"PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis","volume":"105","author":"Granito","year":"2010","journal-title":"Am J Gastroenterol"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898112001647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898112001647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T19:00:11Z","timestamp":1687374011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898112001647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":35,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0009898112001647"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2012.03.020","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}